Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

ClinicalTrials.gov ID: NCT07187531

Public ClinicalTrials.gov record NCT07187531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 10, 2026, 12:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Dose Finding Study Evaluating the Efficacy and Safety of SAB-142 for Delaying the Progression of Type 1 Diabetes (T1D) in Patients With Stage 3 New Onset of Type 1 Diabetes (NOT1D)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).

Study identification

NCT ID
NCT07187531
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
SAb Biotherapeutics, Inc.
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
5 Years to 40 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 24, 2025
Primary completion
Oct 31, 2027
Completion
Nov 30, 2028
Last update posted
Aug 23, 2026

2025 – 2028

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
University of California San Francisco Benioff Children's Hospital San Francisco California 94158 Recruiting
San Jose Clinical Trials, LLC San Jose California 95128 Active, not recruiting
University of Colorado - Barbara Davis Center for Diabetes Aurora Colorado 80045 Recruiting
University of Florida College of Medicine Gainesville Florida 32610 Recruiting
University of Miami - Gables One Tower Miami Florida 33136 Recruiting
Children's Healthcare of Atlanta (CHOA) - Center for Advanced Pediatrics Atlanta Georgia 30329 Recruiting
IUH - Riley Hospital for Children - Riley Outpatient Center - Pediatric Diabetes & Endocrinology Indianapolis Indiana 46202 Recruiting
Harvard Medical School - Joslin Diabetes Center and Joslin Clinical (JDS) Boston Massachusetts 02215 Recruiting
Children's Mercy Hospital Kansas City - Pediatric Care Clinic Kansas City Missouri 64111 Recruiting
University of New Mexico Hospital Albuquerque New Mexico 87106 Not yet recruiting
University at Buffalo MD Physicians Group Buffalo New York 14203 Recruiting
Asheville Clinical Research Asheville North Carolina 28803 Recruiting
N.C. Children's Hospital - Children's Specialty Clinics - Chapel Hill at Carolina Pointe II Chapel Hill North Carolina 27514 Recruiting
Sanford Medical Center Fargo Fargo North Dakota 58104 Recruiting
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 Recruiting
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 Not yet recruiting
Children's Medical Centre Dallas Dallas Texas 75235 Recruiting
Cook Children's Medical Center Fort Worth Texas 76104 Recruiting
Texas Children's Hospital - Clinical Care Center - Pediatric Renal Clinic Houston Texas 77030 Recruiting
San Antonio Clinical Trials San Antonio Texas 78240 Recruiting
University of Virginia Health System - Pediatric Diabetes Clinic Charlottesville Virginia 22903 Recruiting
Benaroya Research Institute at Virginia Mason Seattle Washington 98101 Recruiting
Mary Bridge Children's Outpatient Center - Tacoma Tacoma Washington 98405-3720 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07187531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07187531 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →